Germany: Court decides on issues related to declaration of division during appeal

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Germany: Court decides on issues related to declaration of division during appeal

According to Section 39 of the German Patent Act, the applicant may divide an application at any time by submitting a declaration of division. The text of the divisional application can be filed within three months of receipt of this declaration.

In a recent decision (19 W (pat) 33/17), the Federal Patent Court had to decide on two issues: (i) to which body the declaration of division has to be submitted during the appeal stage, and (ii) whether or not re-establishment of rights for submitting this declaration can be requested.

In this particular case, a patent application was rejected by the examining division of the German Patent and Trademark Office (GPTO), and the applicant filed an appeal with the Federal Patent Court. However, the appeal was dismissed. Within the time limit for filing an appeal on points of law with the Federal Court of Justice, the applicant submitted a declaration of division to the GPTO but not to the Federal Patent Court. Shortly after expiry of the time limit, the GPTO forwarded the declaration of division to the Federal Patent Court. As the applicant did not appeal the decision of the Federal Patent Court, the application was not pending anymore at the time when the GPTO forwarded the declaration of division to the Federal Patent Court.

Based on the following reasoning, the Federal Patent Court decided that no effective declaration of division had been submitted.

While an application is pending in the appeal stage, the declaration of division is to be submitted exclusively to the Federal Patent Court. This also applies if the Federal Patent Court has already issued its decision on the appeal. In this case, the Federal Patent Court remained the competent authority to decide on whether or not an effective declaration of division was submitted and, if effective, on patentability of the divisional application.

Furthermore, the Federal Patent Court decided that Section 39 of the German Patent Act does not contain – not even implicitly – a time limit, which is why no re-establishment of rights for submitting a declaration of division is possible. The approach taken by the Federal Patent Court is in line with the case law of the Boards of Appeal (e.g. J 10/12).

The Federal Patent Court considered both issues i.e. the correct addressee for the declaration of division during the appeal stage (in particular if the Federal Patent Court has already issued its decision on the appeal), and the re-establishment of rights for the declaration of division as legal matters of fundamental importance and therefore allowed an appeal to the Federal Court of Justice.

haggenmuller.jpg

Christian Haggenmüller


Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbH

Elisenhof, Elisenstr 3D-80335, Munich, GermanyTel: +49 89 74 72 660 Fax: +49 89 77 64 24info@maiwald.euwww.maiwald.eu

more from across site and SHARED ros bottom lb

More from across our site

HGF’s new ownership model frees it from the hiring constraints of traditional partnerships, its CEO told Managing IP
New timeline for 2026 aims to provide clearer guidance to firms and practitioners on the full jurisdictional market view
Attorneys contemplate whether clients using AI for legal guidance is beneficial to attorney-client relationships or more of a nuisance
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Gift this article